Hydrocortisone Lotion label

Hydrocortisone Lotion

Hydrocortisone Lotion Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

History

There is currently no drug history available for this drug.

Other Information

Each mL of Hydrocortisone Lotion USP, 2.5% contains 25 mg of hydrocortisone, USP in a vehicle consisting of carbomer homopolymer type C, ceteareth-20, cetyl alcohol, dehydroacetic acid, DMDM hydantoin, fragrance, glyceryl stearate, isopropyl palmitate, lactic acid, light mineral oil, myristyl alcohol, myristyl lactate, PEG-100 stearate, purified water, sodium hydroxide, sodium PCA, and stearyl alcohol.

Chemically, hydrocortisone is [Pregn-4-ene-3,20-dione, 11, 17, 21-trihydroxy-, (11ß)-] with the molecular formula (C21H30O5) and is represented by the following structural formula:

image of chemical structure

Its molecular weight is 362.46 and its CAS Registry Number is 50-23-7. The topical corticosteroids, including hydrocortisone, constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents.

Hydrocortisone Lotion Manufacturers

  • Physicians Total Care, Inc.
    Hydrocortisone Lotion | Physicians Total Care, Inc.
    No Recall

    Hydrocortisone Lotion | Physicians Total Care, Inc.

    Hydrocortisone Lotion | Physicians Total Care, Inc.

    Shake well before using. Topical corticosteroids are generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.

    If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

  • Qualitest Pharmaceuticals
    Hydrocortisone Lotion | Qualitest Pharmaceuticals
    No Recall

    Hydrocortisone Lotion | Qualitest Pharmaceuticals

    Hydrocortisone Lotion | Qualitest Pharmaceuticals

    Topical corticosteroids are generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.

    If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

  • Perrigo New York Inc
    Hydrocortisone Lotion | Perrigo New York Inc
    No Recall

    Hydrocortisone Lotion | Perrigo New York Inc

    Hydrocortisone Lotion | Perrigo New York Inc

    adults and children 2 years of age and older:

    apply to affected area not more than 3 to 4 times daily

    children under 2 years of age:

    do not use. Ask a doctor.

    for external anal itching:

    adults: when practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product. children under 12 years of age with external anal itching: ask a doctor
  • E.fougera & Company A Division Of Fougera Pharmaceuticals Inc.
    Hydrocortisone Lotion | Astrazeneca Pharmaceuticals Lp
    No Recall

    Hydrocortisone Lotion | Astrazeneca Pharmaceuticals Lp

    Hydrocortisone Lotion | Astrazeneca Pharmaceuticals Lp
    2.1 Recommended Dosage

    The recommended dosage of ONGLYZA is 2.5 mg or 5 mg once daily taken regardless of meals. ONGLYZA tablets must not be split or cut.

    2.2 Dosage in Patients with Renal Impairment

    No dosage adjustment for ONGLYZA is recommended for patients with mild renal impairment (creatinine clearance [CrCl] >50 mL/min).

    The dosage of ONGLYZA is 2.5 mg once daily (regardless of meals) for patients with moderate or severe renal impairment, or with end-stage renal disease (ESRD) requiring hemodialysis (creatinine clearance [CrCl] ≤50 mL/min) [see Clinical Pharmacology (12.3) and Clinical Studies (14.3)]. ONGLYZA should be administered following hemodialysis. ONGLYZA has not been studied in patients undergoing peritoneal dialysis.

    Because the dosage of ONGLYZA should be limited to 2.5 mg based upon renal function, assessment of renal function is recommended prior to initiation of ONGLYZA and periodically thereafter. Renal function can be estimated from serum creatinine using the Cockcroft-Gault formula or Modification of Diet in Renal Disease formula. [see Clinical Pharmacology (12.3)].

    2.3 Dosage Adjustment with Concomitant Use of Strong CYP3A4/5 Inhibitors

    The dosage of ONGLYZA is 2.5 mg once daily when coadministered with strong cytochrome P450 3A4/5 (CYP3A4/5) inhibitors (e.g., ketoconazole, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, and telithromycin). [see Drug Interactions (7.1) and Clinical Pharmacology (12.3)].

    2.4 Concomitant Use with an Insulin Secretagogue (e.g., Sulfonylurea) or with Insulin

    When ONGLYZA is used in combination with an insulin secretagogue (e.g., sulfonylurea) or with insulin, a lower dose of the insulin secretagogue or insulin may be required to minimize the risk of hypoglycemia. [see Warnings and Precautions (5.2)].

  • Perrigo New York Inc
    Hydrocortisone Lotion | Ncs Healthcare Of Ky, Inc Dba Vangard Labs
    No Recall

    Hydrocortisone Lotion | Ncs Healthcare Of Ky, Inc Dba Vangard Labs

    Hydrocortisone Lotion | Ncs Healthcare Of Ky, Inc Dba Vangard Labs

    Therapy should be individualized according to patient response. Use the smallest dosage necessary to achieve the required response.

    Adults For Edema

    The usual adult dosage is 25 mg to 100 mg daily as a single or divided dose. Many patients with edema respond to intermittent therapy, i.e., administration on alternate days or on 3 to 5 days each week. With an intermittent schedule, excessive response and the resulting undesirable electrolyte imbalance are less likely to occur.

    For Control of Hypertension

    The usual initial dose in adults is 25 mg daily given as a single dose. The dose may be increased to 50 mg daily, given as a single or two divided doses. Doses above 50 mg are often associated with marked reductions in serum potassium (see also PRECAUTIONS).

    Patients usually do not require doses in excess of 50 mg of hydrochlorothiazide daily when used concomitantly with other antihypertensive agents.

    Infants and Children For Diuresis and For Control of Hypertension

    The usual pediatric dosage is 0.5 mg to 1 mg per pound (1 to 2 mg/kg) per day in single or two divided doses, not to exceed 37.5 mg per day in infants up to 2 years of age or 100 mg per day in children 2 to 12 years of age. In infants less than 6 months of age, doses up to 1.5 mg per pound (3 mg/kg) per day in two divided doses may be required. (See PRECAUTIONS, Pediatric Use.)

    Adults For Edema

    The usual adult dosage is 25 mg to 100 mg daily as a single or divided dose. Many patients with edema respond to intermittent therapy, i.e., administration on alternate days or on 3 to 5 days each week. With an intermittent schedule, excessive response and the resulting undesirable electrolyte imbalance are less likely to occur.

    For Control of Hypertension

    The usual initial dose in adults is 25 mg daily given as a single dose. The dose may be increased to 50 mg daily, given as a single or two divided doses. Doses above 50 mg are often associated with marked reductions in serum potassium (see also PRECAUTIONS).

    Patients usually do not require doses in excess of 50 mg of hydrochlorothiazide daily when used concomitantly with other antihypertensive agents.

    For Edema

    The usual adult dosage is 25 mg to 100 mg daily as a single or divided dose. Many patients with edema respond to intermittent therapy, i.e., administration on alternate days or on 3 to 5 days each week. With an intermittent schedule, excessive response and the resulting undesirable electrolyte imbalance are less likely to occur.

    For Control of Hypertension

    The usual initial dose in adults is 25 mg daily given as a single dose. The dose may be increased to 50 mg daily, given as a single or two divided doses. Doses above 50 mg are often associated with marked reductions in serum potassium (see also PRECAUTIONS).

    Patients usually do not require doses in excess of 50 mg of hydrochlorothiazide daily when used concomitantly with other antihypertensive agents.

    Infants and Children For Diuresis and For Control of Hypertension

    The usual pediatric dosage is 0.5 mg to 1 mg per pound (1 to 2 mg/kg) per day in single or two divided doses, not to exceed 37.5 mg per day in infants up to 2 years of age or 100 mg per day in children 2 to 12 years of age. In infants less than 6 months of age, doses up to 1.5 mg per pound (3 mg/kg) per day in two divided doses may be required. (See PRECAUTIONS, Pediatric Use.)

    For Diuresis and For Control of Hypertension

    The usual pediatric dosage is 0.5 mg to 1 mg per pound (1 to 2 mg/kg) per day in single or two divided doses, not to exceed 37.5 mg per day in infants up to 2 years of age or 100 mg per day in children 2 to 12 years of age. In infants less than 6 months of age, doses up to 1.5 mg per pound (3 mg/kg) per day in two divided doses may be required. (See PRECAUTIONS, Pediatric Use.)

  • Hydrocortisone Lotion | 21st Century Healthcare Inc.
    No Recall

    Hydrocortisone Lotion | 21st Century Healthcare Inc.

    Hydrocortisone Lotion | 21st Century Healthcare Inc.

    •pre-bathe animal with a mild shampoo and dry thoroughly

    •if necessary, spread coat apart with fingers to expose irritated area

    •massage lotion directly on the affected area

    •only a thin coat is necessary

    •small applications at frequent intervals give best results

    •for long haired breeds, it may be necessary to clip hair from irritated area to expose skin

    •when using this product- avoid in contact with the eyes.